Back
In the News

Diane Hazel Comments on FTC-Amazon Antitrust Suit

27 September 2023

Foley & Lardner LLP partner Diane Hazel is quoted in the Reuters article, “FTC’s Amazon antitrust lawsuit faces high bar in US court – experts,” commenting on the U.S. Federal Trade Commission (FTC) and 17 state attorney generals’ recently filed lawsuit against Amazon.com, Inc. alleging that the online retail and technology company is a monopolist engaged in anticompetitive behavior.

Hazel explained that as part of the case, Amazon will have a chance to assert pro-competitive justifications for its alleged conduct, noting that the company would need to show its reasons are “legitimate” to count the FTC’s claims.

Hazel’s comments also appeared in Business of Fashion, Investing.com, U.S. News & World Report, and Yahoo! Finance.

People

Diane Hazel

Partner

Denver 720.437.2034

Related News

View All Posts
25 July 2024 In the News

Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’

Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024 In the News

Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO

Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024 In the News

Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’

Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”